Focus

Molecular Diagnostics Investors: Angels and VC Firms

The RaiseHunt database lists 57 Molecular Diagnostics investors: 33 angel investors and 24 people at 4 firms. Most list Seed and Series A among their stages; the largest hubs are San Francisco, Shanghai and Hong Kong.

Strongest in San Francisco, Shanghai and Hong Kong

Common stages: Seed and Series A

57
Molecular Diagnostics investors
33
Angel investors
24
People at VC/PE firms
4
Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

57 Molecular Diagnostics investors

Showing 1-20

Filters
Reed Sturtevant
Reed Sturtevant

Managing Director

Lexington, United States
Angel
EnergyFinTech
View profile
Cyriac Roeding
Cyriac Roeding

Investor

Portola Valley, United States
AngelOperator angel
AIHealthcare
View profile
Naveen Jain
Naveen Jain

angel investor and operator angel

Bellevue, United States
AngelOperator angel
AIConsumer
View profile
Ameera Shah
Ameera Shah

angel investor

Mumbai, India
Angel
AIHealthcare
View profile
Ryan Fukushima
Ryan Fukushima

angel investor and operator angel

Chicago, United States
AngelOperator angel
AIHealthcare
View profile
Art Pappas
Art Pappas

Founder

Durham, United States
Angel
Healthcare
View profile
XiangQian XQ Lin
XiangQian XQ Lin

CEO

Singapore
AngelOperator angel
Healthcare
View profile
Akash Gehani
Akash Gehani

angel investor and operator angel

Bengaluru, India
AngelOperator angel
ConsumerHardware
View profile
Noah Zimmerman
Noah Zimmerman

angel investor and operator angel

San Francisco, United States
AngelOperator angel
AIHealthcare
View profile
Jeanette Welsh
Jeanette Welsh

Investor

San Francisco, United States
Private equityVenture capital
AICommerce
View profile
Alex Herzick
Alex Herzick

Partner

Durham, United States
Private equityVenture capital
AICommerce
View profile
Tom Raffin
Tom Raffin

General Partner/Co-Founder

San Francisco, United States
Private equityVenture capital
AICommerce
View profile
Rishi Kacker
Rishi Kacker

angel investor

San Francisco, United States
Angel
Healthcare
View profile
Lizzie Ngo
Lizzie Ngo

angel investor and operator angel

Boston, United States
AngelOperator angel
Healthcare
View profile
Norbert Bischofberger
Norbert Bischofberger

angel investor and operator angel

San Mateo, United States
AngelOperator angel
Healthcare
View profile
Rakesh Somani
Rakesh Somani

angel investor

Surat, India
Angel
ConsumerFood
View profile
Fred Craves
Fred Craves

Owner

San Francisco, United States
Private equityVenture capital
Healthcare
View profile
Soenke Weissenborn
Soenke Weissenborn

angel investor

Aachen, Germany
Angel
Healthcare
View profile
NJ
Nickhil Jakatdar

First Investor

Los Altos, United States
AngelOperator angel
ConsumerHealthcare
View profile
RM
Roger Moody

Chief Executive Officer

Chicago, United States
Angel
Healthcare
View profile

Frequently asked questions

How many Molecular Diagnostics investors are on RaiseHunt?

RaiseHunt currently lists 57 Molecular Diagnostics investors.

Are Molecular Diagnostics investors angels or funds?

Both. 33 are angel investors putting in their own money, and 24 are people making investment decisions at 4 firms.

Where are most Molecular Diagnostics investors based?

The largest concentrations are in San Francisco, Shanghai and Hong Kong.

What stage do Molecular Diagnostics investors invest at?

Most list Seed and Series A among the rounds they take part in.

How do I contact Molecular Diagnostics investors?

Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.

Is the list of Molecular Diagnostics investors free to browse?

Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.

Do Molecular Diagnostics investors only back Molecular Diagnostics companies?

No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.

Should I raise from one investor or several?

Several, in almost every case. A single backer concentrates the risk of the round collapsing if that one conversation goes cold, and a group brings more introductions later. Rounds are usually assembled from a lead plus others who follow.

How do I follow up without being annoying?

Follow up with new information rather than a reminder. A short note saying what changed since you last wrote gives the reader a reason to reply, where "just checking in" gives them none. Two or three of those, spaced out, is normal and expected.

What if no Molecular Diagnostics investor replies?

Usually the list was too short or too loosely matched, not that the company is unfundable. Widen it, tighten who you are writing to, and rewrite the first two lines of the message. Those lines decide whether anything below them gets read.

What is the difference between an angel investor and a VC fund?

An angel invests their own money and can decide alone, which usually makes the process shorter. A fund invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a fund once there is more to show.

How many Molecular Diagnostics investors should I contact?

Far more than feels comfortable. Response rates on cold outreach are low even when the fit is good, so a list of a handful of perfect names tends to stall. Build a long list, sort it by how well each one matches what you are building, and work down it in batches rather than sending everything at once.

Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal